-
Maintenance regimen a potential new standard in extensive-stage small cell lung cancer
23 May 2025 22:53 GMT
… extensive-stage small cell lung cancer, according to study … Devastating diagnosis’
Small cell lung cancer — the most aggressive subtype … lung cancer cases.
About 70% of small cell lung cancers … L1 antibody atezolizumab plus carboplatin and etoposide.
Patients …
-
FDA Grants Fast Track Designation to ZL-1310 in Small Cell Lung Cancer
21 May 2025 20:58 GMT
… extensive-stage small cell lung cancer, according to a … study in small cell lung cancer later this year, … Small Cell Lung Cancer and DLL3?
Small cell lung cancer (SCLC) … without carboplatin — in patients with extensive-stage small cell lung cancer. …
-
Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma
23 May 2025 15:50 GMT
… cancers, including non-small cell lung cancer, melanoma, and TNBC.16–18 … neoadjuvant chemotherapy with or without carboplatin and bevacizumab in triple-negative …
-
Man presents with intermittent blurred vision, photophobia
23 May 2025 15:06 GMT
… disease, non-small cell lung cancer and ocular hypertension. He … of non-small cell lung cancer and the temporal relationship … while on pemetrexed and carboplatin, including night sweats, tremulousness … or non-small cell lung cancer with BRAF V600E+ mutations …
-
ASCENT-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors
23 May 2025 12:41 GMT
… choice, which included gemcitabine plus carboplatin, paclitaxel, or nab-paclitaxel. Treatment … than 90% of breast and lung cancers. Trodelvy is intentionally designed with …
-
Lurbinectedin Plus Atezolizumab Maintenance Shows Improved Survival vs Atezolizumab in SCLC
23 May 2025 06:16 GMT
… induction therapy of atezolizumab, carboplatin, and etoposide.
At … extensive-stage small cell lung cancer,” Paz-Ares said. … extensive-stage small cell lung cancer (ES-SCLC): primary … with extensive-stage small-cell lung cancer (IMforte). ClinicalTrials.gov. …
-
RWJBarnabas Health and Rutgers Cancer Institute to Present Practice-Changing Research at 2025 ASCO Annual Meeting
23 May 2025 02:57 GMT
… phase II study of pembrolizumab, carboplatin, paclitaxel, and radiation for the … mutant oligometastatic non small cell lung cancer treated with combination definitive chemoradiotherapy …
-
Zepzelca Plus Tecentriq Boosts Survival in First-Line ES-SCLC Care
23 May 2025 02:23 GMT
… with extensive-stage small cell lung cancer (ES-SCLC), first-line … de Octubre, H12O-CNIO Lung Cancer Unit, Universidad Complutense and … approximately 15% of all lung cancer cases, and 70% of … treatment with Tecentriq plus carboplatin and etoposide for four …
-
Frontline Lurbinectedin Plus Atezolizumab Enhances Survival in ES-SCLC
23 May 2025 01:12 GMT
… extensive-stage small cell lung cancer (ES-SCLC), according … de Octubre, H12O-CNIO Lung Cancer Unit, Universidad Complutense and … treatment with atezolizumab plus carboplatin and etoposide for 4 … extensive-stage small cell lung cancer (ES-SCLC): primary …
-
Bristol Myers Squibb to Present Data at ASCO® 2025 Highlighting Differentiated Research Platform of Oncology Treatments and Innovative Research Pipeline
22 May 2025 21:28 GMT
… NIVO+IPI) vs gemcitabine-carboplatin (gem-carbo) chemotherapy … -Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC) … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, …
About
© 1995-2025